Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5928512 | American Heart Journal | 2014 | 11 Pages |
Abstract
Close to 20% of patients with NSTEMI and 3VD/LMD identified during in-hospital angiography are treated with MMS without revascularization in contemporary practice. Since the use of MMS varies widely across hospitals despite a relatively similar hospital-level case mix, these findings suggest that there is no standard threshold for the use of revascularization in NSTEMI patients with 3VD/LMD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ralf E. MD, Tracy Y. MD, MHS, MSc, Deepak L. MD, MPH, Stephen D. MD, Ezra A. MD, Shuang MS, Laine PhD, Robbert J. MD, PhD, Matthew T. MD, MHS,